Neuralstem
www.neuralstem.com

Neuralstem, Inc. is focused on developing and commercializing of treatments for central nervous system disease based on transplanting human neural stem cells and small molecule drugs. The Company has developed and maintain a portfolio of patents and patent applications that form the base of its research and development efforts in the areas of neural stem cell research, small molecule research, and related technologies.

Additional Information
Market: NYSE AMEX
Sector: Pharmaceuticals
EPIC: CUR
Latest Price: 3.79  (0.26% Ascending)
52-week High: 4.66
52-week Low: 1.11
Market Cap: 295.19M
1 year chart
1 day chart